Search papers, labs, and topics across Lattice.
This review analyzes computational methods for cell-free DNA (cfDNA) analysis aimed at multi-cancer early detection (MCED), highlighting the extraction and analysis of fragmentomics and epigenetic features. By evaluating classical statistical, machine learning, and deep learning approaches, the study emphasizes the biological interpretability and clinical readiness of these methods. The findings suggest that multimodal ensemble approaches hold the greatest potential for clinical integration, while also identifying the need for standardized evaluation protocols to facilitate future comparisons and advancements in the field.
Multimodal ensemble approaches for cfDNA analysis could revolutionize early cancer detection, but standardization is crucial for progress.
Cell-free DNA (cfDNA) is a promising avenue for non-invasive multicancer early detection (MCED), in that, it can enable multiple cancer detection simultaneously from a single blood draw, with particular sensitivity to cancers that currently lack established screening programs. Here we review the computational methods developed between 2022 and 2025 for cfDNA-based MCED. We focus on how fragmentomics and epigenetic features are extracted and analyzed to detect cancer at early stages. We first briefly outline the biological basis of cfDNA signals, then review classical statistical and machine learning approaches alongside deep learning frameworks including autoencoder-based models. For each method we discuss biological interpretability, validation strategy, and readiness for clinical integration. Furthermore, we categorize the current challenges into technical, computational, and methodological while outlining open problems in the field. This review shows that multimodal ensemble approaches have the strongest promise for clinical integration and the highest readiness. However, for better assessment of future work and side-by-side comparison, standardization of evaluation protocols and reporting results will be crucial.
